PMV Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.20 | $37.63 M | -0.56 | 75 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$13.17 | $1.51 B | -9.26 | 117 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.71 | $928.10 M | -3.8 | 51 |
![]() MNOV
MediciNova, Inc. |
$1.30 | $65.23 M | -5.78 | 13 |
![]() PHVS
Pharvaris N.V. |
$17.00 | $944.64 M | -5.33 | 108 |
![]() RLYB
Rallybio Corporation |
$0.33 | $14.36 M | -0.32 | 25 |
![]() TRDA
Entrada Therapeutics, Inc. |
$6.91 | $267.57 M | 12.16 | 183 |
![]() PEPG
PepGen Inc. |
$1.15 | $44.50 M | -0.43 | 79 |
![]() VIGL
Vigil Neuroscience, Inc. |
$7.95 | $370.81 M | -3.86 | 69 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$4.60 | $292.79 M | 39.67 | 142 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.46 | $59.57 M | -5.8 | 2 |
![]() ELYM
Eliem Therapeutics, Inc. |
$1.24 | $342.68 M | -2.3 | 9 |
![]() OPT
Opthea Limited |
$3.41 | $4.20 B | -1.52 | 33 |
![]() MOLN
Molecular Partners AG |
$3.74 | $136.10 M | -1.77 | 158 |